Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VAMOS: Olmesartan in Hypertensive Patients with Metabolic Syndrome
NCT00891267Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Oct 2008
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of olmesartan in hypertension (HTN), sponsored by Daiichi Sankyo Co., Ltd.. Started Oct 2008; status: completed.
02
Drugs
olmesartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00891267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00891267.